이 누리집은 대한민국 공식 전자정부 누리집입니다.
연구사업
연구자원
연구성과
알림자료
연구원 소개
연구사업
연구자원
* `07년 이후 4,127명 등록 및 2,122명 유지
* 누적 7,626건
코호트 운영 흐름도
준비중입니다. |
Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea (Clin Mol Hepatol, 2023) | 초록보기 |
Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C (Sci Rep, 2023) | 초록보기 |
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study(Clin Mol Hepatol, 2023) | 초록보기 |
The Seroprevalence of Anti-hepatitis C Virus Antibody in the Persons Who Inject Drugs in South Korea: a Multicenter, Retrospective Study during 2012-2022 (JKMS, 2023) | 초록보기 |
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective (Clinical molocular hepatology, 2022) | 초록보기 |
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study (World J Gastroenterol, 2022) | 초록보기 |
Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in South Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID. (Epidemiology and Health, 2021) | 초록보기 |
Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study. (Gut Liver, 2020) | 초록보기 |
Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study. (Korean J Intern Med, 2020) | 초록보기 |
Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study. (Gut Liver, 2020) | 초록보기 |
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea. (Gut Liver, 2020) | 초록보기 |
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose. (Gut Liver, 2020) | 초록보기 |
Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D. (Gut and Liver 2019) | 초록보기 |
자원 수집 현황
게시물 저장 중입니다.